Cellular rejuvenation compounds

Use of at least a compound (I) made from hydroxystilbene oligomers and their alkyl-ethers and/or esters for non-therapeutic cosmetic use, preferably to: reduce and/or revitalize cells, preferably cells of the epidermis and/or dermis, delay the transition of the cells, preferably the cells of the epidermis and/or dermis of the proliferative status in the dormant or senescent status, reduce the portion of the cells, preferably the cells in the epidermis and/or dermis in the dormant or senescent status, and impart a young phenotype around the skin, is claimed. An independent claim is included for a composition comprising at least a hydroxyl-stilbene oligomer or its alkyl-ether or ester in combination with at least an active agent, preferably aporphine-alkaloid, purine and/or its derivative, natural betaine compound, alkyl or hydroxy alkyl substituted urea compound, monomer, oligomer or polymer of amino acids, N-2-24C-acylamino acid and/or its ester or salts and/or polysaccharide, in a suitable carrier. Die Erfindung betrifft die Verwendung von Hydroxystilbenen und/oder Hydroxystilben-Oligomeren, deren Alkylethern und/oder deren Estern, zur verjüngenden Behandlung von Zellen, insbesondere zur verjüngenden Behandlung von Zellen der Epidermis und/oder der Dermis.